DMK Pharmaceuticals OverviewDMK Pharmaceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for DMK.
Quarterly EBIT
-$4.34M
↑ 17.16% YoY
As of Dec 31, 2022
Annual EBIT (TTM)
-$25.06M
↑ 21.86% YoY
Trailing 12 months ending Dec 31, 2022
DMK Pharmaceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for DMK.
As of Dec 31, 2022
Trailing 12 months ending Dec 31, 2022